Patent Grant
10178991
This application claims benefit of and priority to European Patent Application Serial No. 15305604.9 filed Apr. 22, 2015, the disclosure of the above-identified application is hereby incorporated by reference in its entirety.
1. Technical Field
The present invention relates to a method for forming a barbed suture in the surgical field. The method of the invention allows producing a high quantity of barbed suture in a reduced time and in a very cost-effective way. The invention also relates to the barbed suture obtained by this method.
2. Background of Related Art
Surgical knots have been used for ages in order to anchor and allow a conventional suture, in other words a smooth suture without barbs, to perform its role in tissue reapproximation for example. Anyway, surgical knots reduce the tensile strength of conventional sutures by thinning and stretching the material forming the suture. Indeed, it is known that the weakest portion of any suture line is the knot.
Moreover, the tying of surgical knots introduces the potential of human error. A knot-secured conventional suture may create an uneven distribution of tension across the wound, with the higher tension burden placed at the knots. In addition, in minimally invasive laparoscopic surgery, the ability to quickly and properly tie surgical knots presents a challenge. The skill necessary for performing intra- or extracorporeal knot tying for laparoscopic surgery may be acquired only with practice and patience, yet surgeons need to master such a skill in order to properly perform closure procedures. Laparoscopic knot tying is also more mentally and physically stressful on surgeons.
Given the excessive relative wound tension on the knot and the reasonable concerns of surgeons for suture failure due to knot slippage, there is a natural tendency toward overcoming these potential issues by over-tightening knots. However, tighter knots may be worse for wound healing and strength than looser knots. Surgical knots, when tied too tightly, can cause localized hypoxia, reduced fibroblast proliferation, and excessive tissue overlap, leading to reduced strength in the healed wound.
Eventually, a surgical knot yields the highest density of foreign body material in any given suture line and the volume of a knot may be directly related to the total amount of surrounding inflammatory reaction. If minimizing the inflammatory reaction in a wound is important for optimized wound healing, then minimizing knots sizes or even eliminating knots altogether would be beneficial as long as the wound-holding strength of the suture line is not compromised.
For all these reasons, the use of barbed suture, suture with barbs, has tremendously increased in the past years. In particular, one of the most costly parts of a surgical procedure is time in the operating room. With rising healthcare costs, efficiency in the operating room is becoming more of a priority. Significantly faster closure times have been observed with the use of knotless barbed sutures. The use of knotless barbed suture can securely reapproximate tissues with less time, cost, and risks.
Barbed sutures are known. They basically consist in strands of smooth suture provided with barbs on their surfaces. Barbed sutures are generally made of the same materials as conventional sutures and offer several advantages for closing wounds compared with conventional sutures. A barbed suture includes an elongated body that has one or more spaced barbs, that project from the surface of the suture body along the body length.
The barbs are generally arranged to allow passage of the barbed suture in one direction through tissue but resist movement of the barbed suture in the opposite direction (one-way suture). One advantage of barbed sutures is the provision of a non-slip property. Barbed sutures are known for use in cosmetic, laparoscopic and endoscopic procedures. The number of barbs needed for a particular suture may be influenced by the size of the wound and the strength required to hold the wound closed. Like a conventional suture, a barbed suture may be inserted into tissue using a surgical needle.
In some circumstances, a random configuration of barbs on the exterior surface of the suture is preferred to achieve optimal holding of the wound closure for a particular wound. However, in other circumstances, where the wound or tissue repair needed is relatively small, a reduced number of barbs may be desired.
Various methods of forming barbs on sutures have been proposed such as mechanical cutting, laser cutting, injection molding, stamping, extrusion and the like. However, such methods may be difficult or costly, in particular when a specific arrangement or configuration of barbs is needed for an appropriate surgical procedure.
For example, conventional cutting methods of forming barbs may involve cutting with a blade into the elongate body of the suture, where the elongate body may be a monofilament for example. Barbed sutures may be fabricated from monofilament fibers by a micro-machining technique, which escarpes barbs into the fiber around the circumference in a variety of configurations. Cutting methods have therefore significant drawbacks as they weaken the core of the suture and narrow its functional diameter. Moreover, they are costly and have slow manufacturing cycle time.
Accordingly, there is a continuous need for methods of forming barbs on a suture that are less difficult to implement, more efficient and cost effective. There is also a continuous need for methods allowing varying the size, the location and the depth of the barbs, as well as the amount of barbs present on the suture, depending on the contemplated surgical application.
A first aspect of the invention is a method for forming a barbed suture comprising an elongate body provided with barbs extending substantially radially out from said elongate body, said method comprising the following steps:
a) producing a knit on a warp knitting machine comprising at least two guide bars, a first guide bar B1 and a second guide bar B2, by knitting together i) a set of chain stitch yarns of a first biocompatible material threaded in said first guide bar B1 and producing chain stitches and ii) a set of monofilament weft yarns of a second biocompatible material threaded in said second guide bar B2, the knitting pattern followed by the second guide bar B2 producing at least a partial weft in which said monofilament weft yarns complete weft stitches with at least one of said chain stitches, thereby producing at least one weft stitched chain stitch,
b) cutting the knit along the warp direction on both sides of said at least one weft stitched chain stitch, so as to isolate said weft stitched chain stitch from the rest of the produced knit,
the chain stitch yarn of said at least one weft stitched chain stitch forming said elongate body of said barbed suture and the monofilament cuts extending from said weft stitches of said at least one weft stitched chain stitch forming said barbs of said barbed suture.
The barbed suture obtained by the method of the invention therefore comprises an elongate body made of a yarn of a first biocompatible material, provided with barbs extending substantially radially out from said elongate body, said barbs being monofilament cuts made of a second biocompatible material, where said monofilament cuts are stitched to said yarn forming said elongate body. Another aspect of the invention is a barbed suture comprising an elongate body made of a yarn of a first biocompatible material, provided with barbs extending substantially radially out from said elongate body, said barbs being monofilament cuts made of a second biocompatible material, where said monofilament cuts are stitched to said yarn forming said elongate body, said barbed suture being obtained by the method above.
In a first step, step a), of the method of the invention, a knit is produced on a warp knitting machine comprising at least two guide bars, a first guide bar B1 and a second guide bar B2, by knitting together i) a set of chain stitch yarns of a first biocompatible material threaded in said first guide bar B1 and producing chain stitches and ii) a set of monofilament weft yarns of a second biocompatible material threaded in said second guide bar B2, the knitting pattern followed by the second guide bar B2 producing at least a partial weft in which said monofilament weft yarns complete weft stitches with at least one of said chain stitches, thereby producing at least one weft stitched chain stitch.
The warp knitting machine may be for example a crochet machine or a raschel knitting machine. Warp knitting machines have a warp yarn for each needle.
By “chain stitch” is meant according to the present application a stitch construction where both over and underlapping are always carried out across the same needle. One chain stitch of a knit therefore involves only one warp yarn, in other words involves only one yarn in the warp direction. The tensile strength of one chain stitch is therefore the tensile strength of said single warp yarn involved in the construction of the chain stitch.
The method of the invention allows producing barbed sutures in a very simple, easy and rapid process. In particular the method of the invention is a cost effective process as there is no need to use sophisticated cutting machines with blades for performing cuts into the body of a monofilament.
It is known that warp knitting machines are capable of producing knits at high production rates. In addition, the knits produced may also show a very long dimension along the warp direction, which is the direction of manufacturing the knit.
As an example, with current existing warp knitting machines, knits of at least 300 meters long may be produced. The method of the invention therefore allows manufacturing a barbed suture of 300 meters long in a very cost effective way, and in particular in only one knitting step.
In addition, the barbs created in the barbed suture produced according to the method for the invention are ineradicable since they are made of monofilament cuts that stitch through chain stitches pillar.
In embodiments, the knitting pattern followed by the second guide bar B2 produces at least a partial weft in which said monofilament weft yarns complete weft stitches with a plurality of chain stitches, thereby producing a plurality of weft stitched chain stitches, and wherein the cutting of step b) is repeated for each weft stitched chain stitch, thereby producing a plurality of barbed sutures.
The method of the invention therefore allows manufacturing simultaneously a plurality of barbed sutures of significant length each.
In current existing warp knitting machines, a high number of chain stitches may be produced along the width of a knit. As an example, 286 or more chain stitches may be produced on the width of a knit. If the knit produced is 300 meters long, this means that at least 85 800 meters of barbed suture may be produced in one single knitting step with the method of the invention. The time needed for producing such 85 800 meters of barbed suture may range for example from 30 hours to 60 hours. In other words, the method of the invention allows producing for example 10 meters of barbed suture per hour.
Guide bar B2 may be fed continuously or intermittently with the monofilament weft yarns during step a). In embodiments, guide bar B2 is fed continuously with the monofilament weft yarns during step a). The method of the invention further allows producing a barbed suture having different functional portions along its length. In particular, the method of the invention allows producing barbed suture having active portions, namely portions provided with barbs, and passive portions, namely portions free of any barbs. The passive portions may be obtained by simply stopping the feeding of the second guide bar B2 with the weft yarns for a certain period of time during the knitting process of step a°) of the method of the invention. Barbed sutures having alternating active portions and passive portions may therefore be obtained by simply intermittently feeding the second guide bar B2 during the knitting process. In embodiments, the second guide bar B2 is fed intermittently with said set of monofilament weft yarns.
Alternatively, barbed sutures having alternating active portions and passive portions may be obtained by modifying the knitting pattern of guide bar B2 so that, for one or several determined time periods during step a) of production of the knit, the monofilament weft yarns do not complete any weft stitches with said weft stitched chain stitch(es).
The method of the invention further allows varying and selecting the length of the barbs according to an easy process. Indeed, the length of the barbs of the barbed sutures obtained with the method of the invention will be dependent first on the distance left between a weft stitched chain stitch and the two adjacent chain stitches on both sides of said weft stitched chain stitch, said distance being a function of the knitting pattern, and second on the location of the cutting line on said distance at the time of the cutting step b) of the method of the invention. The distance left between a weft stitched chain stitch and the two adjacent chain stitches will be function of the threading-in of the two guide bars, in particular of the threading-in of the first guide bar B1 forming the chain stitches. The greater the distance desired, the more empty needles left between two full needles. On the contrary, the smaller the distance desired between two adjacent weft stitched chain stitches, the less empty needles left between two full needles.
In embodiments, the first guide bar B1 is threaded 1 full, 3 empty. Alternatively, the first guide bar B1 may be threaded 1 full, 4 empty, or 1 full, 5 empty.
In embodiments, the knitting pattern followed by bars B1 and B2 is the following according to the ISO 11676 standard:
wherein B1 is threaded 1 full, 3 empty, and B2 is threaded 1 full, 7 empty, along the whole width of the machine.
Such a pattern results in a distance between a weft stitched chain stitch and the two adjacent chain stitches of about 5 mm.
In other embodiments, the knitting pattern followed by bars B1 and B2 is the following according to the ISO 11676 standard:
wherein B1 is threaded 1 full, 3 empty, and B2 is threaded 1 full, 7 empty, along the whole width of the machine.
Such a pattern results in a distance between a weft stitched chain stitch and the two adjacent chain stitches of about 5 mm.
The method of the invention also allows varying and selecting the amount or number of barbs along the length of the suture in an easy way. In particular, the method of the invention allows selecting a specific frequency of barbs along the length of the suture, in other words a number of barbs per centimeter of suture. Such a frequency will depend on the knitting pattern followed by the second guide B2 threaded with the monofilament weft yarns. In particular, the more weft stitches completed along the warp direction of the chain stitch, the more weft stitches present on the isolated weft stitched chain stitch in the end, and the higher the frequency of barbs on the resulting barbed suture. In embodiments, the knitting pattern followed by the second guide bar B2 produces a partial weft in which said monofilament weft yarns complete from about 4 to about 15 weft stitches/cm along a length of each said weft stitched chain stitch.
In addition, the method of the invention allows producing barbed sutures without affecting the tensile strength of the elongate body of the barbed suture. Indeed, contrary to cutting methods of the prior art which create the barbs by performing cuttings in the elongate body of the suture, made of a monofilament for example, the method of the invention leaves the yarn forming the elongate body of the suture integrate. The integrity of the yarn is not affected. As a consequence, the tensile strength of the yarn forming the elongate body of the barbed suture obtained by the method of the invention is not affected by the presence of the barbs. Moreover, the method of the invention allows using both monofilaments and multifilaments yarns as the elongate body of the suture, whereas the methods involving cutting steps request that the elongate body be a unitary structure, such as a monofilament yarn.
In embodiments, the chain stitch yarns, that will form the elongate body of the barbed suture, may be monofilaments or multifilaments. In embodiments, the chain stitch yarns are monofilaments yarns, for example having a diameter ranging from about 0.07 mm to about 0.3 mm. In embodiments, the chain stitch yarns are multifilaments. Existing multifilament yarns may show high tenacity, in other words, high tensile strength. In embodiments, the chain stitch yarns may be multifilament yarns having a tensile strength ranging from about 25 cN/dTex to about 40 cN/dTex, for example a tensile strength of about 35 cN/dTex.
The method of the invention allows producing barbed sutures with barbs having varying surface area in a very easy way. In particular, the size and/or the surface area of the barbs of the suture obtained by the method of the invention will be dependent on the size of the diameter of the monofilament weft yarns. In embodiments, the monofilament weft yarns show a diameter ranging from 0.07 mm to 0.3 mm. Such a diameter allows obtaining a good fixation of the barbed suture within the biological tissues.
Barbs of varying size may be desired depending on the contemplated surgical application. For joining fat and relatively soft tissues, larger barbs may be desired, whereas smaller barbs may be more suitable for collagen-dense tissues. With the method of the invention, the production of small or alternatively large barbs may be easily obtained by simply selecting monofilament weft yarns of adequate diameters. For example, for obtaining a barbed suture with large barbs according to the method of the invention, monofilament weft yarns with a diameter ranging from 0.2 mm to 0.3 mm may be used. In embodiments, the monofilament weft yarns may show a diameter ranging from 0.2 mm to 0.3 mm. Alternatively, for obtaining a barbed suture with small barbs according to the method of the invention, monofilament weft yarns with a diameter ranging from 0.07 mm to 0.1 mm may be used. In embodiments, the diameter of the monofilament weft yarn may range from 0.07 mm to 0.1 mm.
In some embodiments, a combination of large and small barbs within the same suture may be desirable, for example when a suture is used in tissue repair with differing layer structures. Use of the combination of large and small barbs with the same suture wherein barb sizes are customized for each tissue layer will ensure maximum anchoring properties. In embodiments, the barbed suture obtained by the method of the invention may have both large and small barbs. Such a barbed suture with a combination of large and small barbs may be obtained with a warp knitting machine including a third guide bar B3, where a first set of monofilament weft yarns of a large diameter, for example ranging from 0.20 mm to 0.25 mm, is threaded on the second guide bar B2, and a second set of monofilament weft yarns of a small diameter, for example ranging from 0.07 mm to 0.09 mm, is threaded on the third guide bar B3.
The barbed suture obtained by the method of the invention is formed of an elongate body made from a chain stitch yarn formed of a first biocompatible material, and of barbs made of monofilaments cuts originating from monofilament weft yarns formed of a second biocompatible material. The first biocompatible material and the second biocompatible material may be identical or different. In embodiments, the first biocompatible material and the second biocompatible material are identical, and the chain stitch yarn and the monofilament weft yarns are therefore made of the same material. In other embodiments, the first biocompatible material and the second biocompatible material are different, and the chain stitch yarn and the monofilament weft yarns are therefore made of different materials.
The first biocompatible material and the second biocompatible material may be synthetic or natural. The first and second biocompatible polymer materials may be biodegradable, non-biodegradable or a combination of biodegradable and non-biodegradable. The term “biodegradable” as used herein is defined to include both bioabsorbable and bioresorbable materials. By biodegradable, it is meant that the materials decompose, or lose structural integrity under body conditions (e.g., enzymatic degradation or hydrolysis) or are broken down (physically or chemically) under physiologic conditions in the body such that the degradation products are excretable or absorbable by the body.
The first and second biocompatible materials may be selected from the group consisting of biodegradable polymers, non-biodegradable polymers, and combinations thereof.
Non-biodegradable materials that may be used as first biocompatible material and second biocompatible material of the method of the invention include polyolefins, such as polyethylene, polypropylene, copolymers of polyethylene and polypropylene, and blends of polyethylene and polypropylene; polyamides (such as nylon); polyamines, polyimines, polyesters such as polyethylene terephthalate; polytetrafluoroethylene; polyether-esters such as polybutester; polytetramethylene ether glycol; 1,4-butanediol; polyurethanes; and combinations thereof. In other embodiments, non-degradable materials may include silk, collagen, cotton, linen, carbon fibers, titanium, and the like. The polypropylene may be isotactic polypropylene or a mixture of isotactic and syndiotactic or atactic polypropylene.
Biodegradable materials that may be used as first biocompatible material and second biocompatible material of the method of the invention include polylactic acid (PLA), polyglycolic acid (PGA), oxidized cellulose, polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoates (PHAs), copolymers of these materials and mixtures thereof.
In embodiments, the first biocompatible material and the second biocompatible material are each selected from polyethylene, polypropylene, polyester such as polyethylene terephthalates, polyamide, silicone, polyether ether ketone (PEEK), polyarylether ether ketone (PAEK), polylactic acid (PLA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoate (PHA), polyglycolic acid (PGA), copolymers of these materials, and mixtures thereof.
In embodiments, the first biocompatible material is polyethylene. The polyethylene may be a ultra high molecular weight polyethylene conferring to a multifilament yarn made therefrom a high tensile strength. In embodiments, the chain stitch yarns may be polyethylene multifilament yarns having a tensile strength ranging from about 25 cN/dTex to about 40 cN/dTex, for example a tensile strength of about 35 cN/dTex. Such polyethylene multifilament yarns made from ultra high molecular weight polyethylene and provided with such a tensile strength are commercially available from the company DSM under the tradename “Dyneema Purity®.
In embodiments, the first biocompatible material is polyethylene terephthalate. In embodiments, the chain stitch yarns may be polyethylene terephthalate multifilament yarns having a tensile strength ranging from about 25 cN/dTex to about 40 cN/dTex, for example a tensile strength of about 35 cN/dTex.
In embodiments, the second biocompatible material is polypropylene. Polypropylene may confer rigidity to the weft monofilaments and therefore to the barbs obtained therefrom.
The method of the invention allows customizing the elongate body and the barbs of the barbed suture in function of the contemplated surgical application. For example, if the barbed suture is to be used to connect the edges of a wound in skin or tendon, the barbs may be made relatively short and more rigid, for example by using polypropylene monofilament weft yarns, to facilitate entry into this rather firm tissue. Alternatively, if the barbed suture is intended for use in fatty tissue, which is relatively soft, the barbs may be made longer and spaced further apart to increase the ability of the suture to grip the soft tissue.
In a second step, step b), of the method of the invention, the knit produced in step a) is cut along the warp direction on both sides of said at least one weft stitched chain stitch, so as to isolate said weft stitched chain stitch from the rest of the produced knit. In embodiments where the knitting pattern followed by the second guide bar B2 produces at least a partial weft in which said monofilament weft yarns complete weft stitches with a plurality of chain stitches, thereby producing a plurality of weft stitched chain stitches, the cutting of step b) is repeated for each weft stitched chain stitch, thereby producing a plurality of barbed sutures. For each such isolated weft stitched chain stitch, the chain stitch yarn will form the elongate body of the thus obtained barbed suture and the monofilament cuts extending from the weft stitches of the weft stitched chain stitch will form the barbs of the thus obtained barbed suture.
In embodiments, the cutting step may be performed on line, namely while the knit produced at step a) is still on the knitting machine. For example, the knitting machine may be provided with adequate blades. Alternatively, the cutting step may be performed off line, for example with pairs of scissors.
In embodiments, the cutting step may be performed via melting the weft monofilaments at a temperature above their melting point so as to cut said monofilaments. Such a cutting step may be perfomed on line or off line.
After cutting step b) of the method of the invention, the monofilament cuts forming the barbs may generally extend substantially radially out of the chain stitch yarn forming the elongate body of the barbed suture along an angle between the monofilaments cuts and the chain stitch yarn of about 90°. In the present application, the angle between the monofilament cuts and the yarn forming the elongate body is measured with a Profile Projector ORAM 300V geometric.
The angle between the monofilament cuts and the yarn forming the elongate body may be modified by submitting the isolated weft stitched chain stitch to a stretching treatment. For example, the angle between the monofilament cuts and the yarn forming the elongate body may be modified so that said angle reaches 45°, 35°, or 33°. The method of the invention therefore allows selecting the adequate angle between the barbs and the elongate body of the barbed suture for an optimized fixation in the biological tissues.
In embodiments, the method further comprises a stretching step during which either the knit produced in step a) or the isolated weft stitched chain stitch resulting from step b) is submitted to a stretching treatment. The stretching treatment may comprise a step of stretching the knit in the warp direction or stretching the isolated weft stitched chain stitch in the direction of its length, in other words in the warp direction. For example, in the case of an isolated weft stitched chain stitch, the stretching treatment may be performed by using a traction testing machine such as Hounsfield model H5KS in which a first end of the isolated weft stitched chain stitch is grasped by a fixed jaw of the machine and the opposite end of the isolated weft stitched chain stitch is grasped by a moving jaw. By moving away from the fixed jaw, the moving jaw stretches the isolated weft stitched chain stitch.
On a industrial scale, the stretching treatment of the knit in the warp direction may be performed on a heat-setting machine for example. By stretching the knit in the warp direction, all weft stitched chain stitch(es) of the knit are stretched.
In embodiments, the weft stitched chain stitch, isolated or not, is stretched from about 0% to about 90%, which means that the stretched weft stitched chain stitch shows a length from about 0% to about 90% greater than the initial length of the weft stitched chain stitch.
In embodiments, the weft stitched chain stitch, isolated or not, is stretched at 40%, which means that the stretched weft stitched chain stitch shows a length 40% greater than the initial length of the weft stitched chain stitch. Such a stretching step of 40% may result in the angle between the monofilament cuts and the yarn forming the elongate body be modified to reach about 45°. Such an angle between the monofilament cuts and the yarn forming the elongate body of the barbed suture may be desirable for barbed sutures intended to be used in soft biological tissues.
In other embodiments the weft stitched chain stitch, isolated or not, is stretched at 80%, which means that the stretched weft stitched chain stitch shows a length 80% greater than the initial length of the weft stitched chain stitch. Such a stretching step of 80% may result in the angle between the monofilament cuts and the yarn forming the elongate body be modified to reach about 35°. Such an angle between the monofilament cuts and the yarn forming the elongate body of the barbed suture may be desirable for barbed sutures intended to be used for anchoring purposes in dense biological tissues such as muscles.
In other embodiments the weft stitched chain stitch, isolated or not, is stretched at 90%, which means that the stretched weft stitched chain stitch shows a length 90% greater than the initial length of the weft stitched chain stitch. Such a stretching step of 90% may result in the angle between the monofilament cuts and the yarn forming the elongate body be modified to reach about 33°. Such an angle between the monofilament cuts and the yarn forming the elongate body of the barbed suture may be desirable for barbed sutures intended to be used for anchoring purposes in dense biological tissues such as muscles.
In embodiments, the isolated weft stitched chain stitch may be submitted to a twisting treatment, for example for giving to the barbs a helical pattern. Such a treatment may be performed with a rotor machine.
In embodiments, the method of the invention further comprises a heat-setting step during which either the knit produced in step a) or the isolated weft stitched chain stitch resulting from step b) is submitted to a heat-setting treatment. The heat-setting treatment is intended to fix the barbed suture in the desired configuration. The heat-setting step may take place either between step a) and b), namely before the cutting step, or after step b), namely after the cutting step. For example, in case the knit or the isolated weft stitched chain stitch is submitted to a stretching treatment and/or a twisting treatment, it may simultaneously be submitted to a heat-setting treatment, so that the barbs configuration regarding for example the angle made between the monofilaments cuts and the elongate body and/or the helical pattern obtained by the twisting treatment are fixed.
The heat-setting treatment may comprise a step of heating the knit or the isolated weft stitched chain stitch at a temperature ranging from 30° C. to 230° C. during a time period ranging from 1 min to 4 min. The heat-setting treatment may be performed on a heat-setting machine.
The barbed suture obtained by the method of the invention may be sterilized by any means within the purview of those skilled in the art.
The barbed suture obtained by the method of the invention may be coated or impregnated with one or more medico-surgically useful substances which accelerate or beneficially modify the healing process when the barbed suture is applied to a wound or surgical site. In certain embodiments, the coating may be formed from biodegradable polymers selected from the group consisting of lactones, carbonates, polyorthoesters, hydroxyalkoanates, hydroxybutyrates, bioactive agents, polyanhydrides, silicone, calcium stearoyl lactylates, vinyl polymers, high molecular weight waxes and oils, natural polymers, proteins, polysaccharides, suspendable particulates, dispersible particulates, microspheres, nanospheres, rods, homopolymers thereof, copolymers thereof, and combinations thereof.
Suitable bioactive agents include, for example, biocidal agents, antimicrobial agents, antibiotics, anti-proliferatives, medicants, growth factors, anti-clotting agents, clotting agents, analgesics, anesthetics, anti-inflammatory agents, wound repair agents and the like, chemotherapeutics, biologics, protein therapeutics, monoclonal or polyclonal antibodies, DNA, RNA, peptides, polysaccharides, lectins, lipids, probiotics, diagnostic agents, angiogenics, anti-angiogenic drugs, polymeric drugs, and combinations thereof.
Bioactive agents include substances which are beneficial and tend to promote the healing process. For example, a barbed suture obtained by the method of the invention can be provided with a bioactive agent that will be deposited at the sutured site. The bioactive agent can be chosen for its antimicrobial properties, capability for promoting wound repair and/or tissue growth, or for specific indications such as thrombosis.
The barbed suture obtained by the method of the invention may additionally comprise a needle at one end. Two tipped ends of the barbed suture may be desirable for attaching a needle to each end of the suture to provide a so-called double armed suture. The needle attachment may be made by any conventional method such as crimping, swaging, and the like. In some cases, a tubular insertion device (not shown) may be utilized to introduce a barbed suture obtained by the method of the invention into tissue.
The barbed suture obtained by the method of the invention may be utilized in any cosmetic, orthopedic, open endoscopic or laparoscopic methods. In addition, barbed sutures obtained by the method of the invention may be utilized to attach one tissue to another including, but not limited to, attaching tissue to a ligament. Specific applications of cosmetic surgeries include, for example, facelifts, browlifts, thigh lifts, and breast lifts. The barbed suture obtained by the method of the invention may further be used as a device for occlusion of a corporeal duct, for example for closing a variscose vein.
The advantages of the method of the invention will appear more clearly from the following examples and attached drawings in which:
A knit is produced on a raschel machine wherein the knitting pattern followed by bars B1 and B2 is the following according to the ISO 11676 standard:
wherein B1 is threaded 1 full, 3 empty, and B2 is threaded 1 full, 7 empty.
The yarns threaded in guide bar Bar 1 are multifilament yarns of ultra high molecular weight polyethylene, such as those marketed by the company DSM under the tradename “Dyneema Purity®”. These multifilaments have a tensile strength of 35 cN/dTex.
The monofilaments threaded in guide bar Bar 2 are polypropylene monofilaments having a diameter of 0.25 mm.
With reference to
With reference to
Once the knit is produced, it is cut along the warp direction on both sides of the weft stitched chain stitches 6 along cutting lines 11 as shown on
An isolated weft stitched chain stitch 6, in which the chain stitch yarn 1 of the weft stitched chain stitch 6 forms the elongate body 9 of a barbed suture 10 and the monofilament cuts 7 extending from the weft stitches 5 of the weft stitched chain stitch 6 form the barbs 8 of the barbed suture 10 is obtained, as shown on
As appears from the cutting step shown on
With reference to
With reference to
The barbed suture 10 of
In embodiments not shown, the knitting pattern may result in all chain stitches being also weft stitched chain stitches, when the weft yarns produce weft stitches with all chain stitches produced by the first guide bar. In other embodiments, the knitting pattern may produce only one weft stitched chain stitch out of three, four, five, etc . . . chain stitches present in the knit, which may result in variations of the distance between two adjacent weft stitched chain stitches. Alternatively, this distance may vary due to different threading-in of the guide bars.
In this example is described an alternative knitting pattern to Example 1 for producing a barbed suture of the invention.
A knit is produced on a raschel machine wherein the knitting pattern followed by bars B1 and B2 is the following according to the ISO 11676 standard:
wherein B1 is threaded 1 full, 3 empty, and B2 is threaded 1 full, 7 empty.
The yarns threaded in guide bar Bar 1 are multifilament yarns of ultra high molecular weight polyethylene, such as those marketed by the company DSM under the tradename “Dyneema Purity®”. These multifilaments have a tensile strength of 35 cN/dTex.
The monofilaments threaded in guide bar Bar 2 are polypropylene monofilaments having a diameter of 0.25 mm.
With reference to
Once the knit is produced, it is cut as described in Example 1 to obtain an isolated weft stitched chain stitch 6.
The isolated weft stitched chain stitch 6 may then be stretched, and/or twisted in order to put the monofilaments cuts 7, also barbs 8, in a desired configuration, and eventually heat-set in order to fix said configuration to obtain a barbed suture 10 of the invention.
The method of the invention allows adapting very easily and in a cost effective manner the nature and structure of the barbed suture, such as frequency per cm, configuration, spacing, length and surface area of the barbs, depending upon the tissue in which the barbed suture is to be used. With the method of the invention, it is possible to obtain a barbed suture in which the barbs may be arranged in any suitable pattern, for example, helical, linear, or randomly spaced. In addition, the method of the invention allows producing a high amount of barbed suture in a cost effective way and at high production rates.
| Number | Date | Country | Kind |
|---|---|---|---|
| 15305604 | Apr 2015 | EP | regional |
| Number | Name | Date | Kind |
|---|---|---|---|
| 71909 | Pierce | Dec 1867 | A |
| 1188668 | Pleukharp | Mar 1877 | A |
| 549555 | White | Nov 1895 | A |
| 709392 | Brown | Sep 1902 | A |
| 816026 | Meier | Mar 1906 | A |
| 3166072 | Sullivan, Jr. | Jan 1965 | A |
| 3221746 | Noble | Dec 1965 | A |
| 3276172 | Hjalmar | Oct 1966 | A |
| 3494006 | Brumlik | Feb 1970 | A |
| 3897713 | Gugle | Aug 1975 | A |
| 4015504 | Rosan, Sr. et al. | Apr 1977 | A |
| 4114624 | Haverstock | Sep 1978 | A |
| 4224946 | Kaplan | Sep 1980 | A |
| 4259959 | Walker | Apr 1981 | A |
| 4647300 | Sheets | Mar 1987 | A |
| 5026385 | Schutte et al. | Jun 1991 | A |
| 5100391 | Schutte et al. | Mar 1992 | A |
| 5209755 | Abrahan et al. | May 1993 | A |
| 5342376 | Ruff | Aug 1994 | A |
| 5403346 | Loeser | Apr 1995 | A |
| 5403347 | Roby et al. | Apr 1995 | A |
| 5470340 | Bezwada et al. | Nov 1995 | A |
| 5502092 | Barrows et al. | Mar 1996 | A |
| 5611986 | Datta et al. | Mar 1997 | A |
| 5633343 | Bezwada et al. | May 1997 | A |
| 5639851 | Bezwada et al. | Jun 1997 | A |
| 5730750 | Haradon | Mar 1998 | A |
| 5769583 | Girbinger | Jun 1998 | A |
| 5797936 | Kleihues | Aug 1998 | A |
| 5834582 | Sinclair et al. | Nov 1998 | A |
| 5868788 | Bezwada et al. | Feb 1999 | A |
| 5869597 | Newman, Jr. et al. | Feb 1999 | A |
| 5951997 | Bezwada et al. | Sep 1999 | A |
| 5954723 | Spetzler | Sep 1999 | A |
| 6090908 | Jamiolkowski et al. | Jul 2000 | A |
| 6102919 | Licata | Aug 2000 | A |
| 6241747 | Ruff | Jun 2001 | B1 |
| 6270517 | Brotz | Aug 2001 | B1 |
| 6388043 | Langer et al. | May 2002 | B1 |
| 6500193 | Bezemer et al. | Dec 2002 | B1 |
| 6554840 | Matsutani et al. | Apr 2003 | B2 |
| 6599310 | Leung et al. | Jul 2003 | B2 |
| 6620178 | Brotz | Sep 2003 | B1 |
| 6692499 | Tormalaet et al. | Feb 2004 | B2 |
| 6794484 | Newman, Jr. et al. | Sep 2004 | B2 |
| 6831149 | Newman, Jr. et al. | Dec 2004 | B2 |
| 6848152 | Genova et al. | Feb 2005 | B2 |
| 6991643 | Saadat | Jan 2006 | B2 |
| 7070858 | Shalaby et al. | Jul 2006 | B2 |
| 7129319 | Shalaby | Oct 2006 | B2 |
| 7225512 | Genova et al. | Jun 2007 | B2 |
| 7276073 | Adams | Oct 2007 | B2 |
| 7371253 | Leung et al. | May 2008 | B2 |
| 7374566 | Schossau | May 2008 | B1 |
| 7445624 | Freier et al. | Nov 2008 | B2 |
| 7601164 | Wu | Oct 2009 | B2 |
| 7624487 | Trull et al. | Dec 2009 | B2 |
| 7806908 | Ruff | Oct 2010 | B2 |
| 7913365 | Genova et al. | Mar 2011 | B2 |
| 7959641 | Sorensen et al. | Jun 2011 | B2 |
| 7967841 | Yuan et al. | Jun 2011 | B2 |
| 7975698 | Browning | Jul 2011 | B2 |
| 7996967 | Genova et al. | Aug 2011 | B2 |
| 7996968 | Genova et al. | Aug 2011 | B2 |
| 8011072 | Genova et al. | Sep 2011 | B2 |
| 8015678 | Genova et al. | Sep 2011 | B2 |
| 8020263 | Genova et al. | Sep 2011 | B2 |
| 8028387 | Genova et al. | Oct 2011 | B2 |
| 8028388 | Genova et al. | Oct 2011 | B2 |
| 8032996 | Trull et al. | Oct 2011 | B2 |
| 8083770 | Ruff et al. | Dec 2011 | B2 |
| 8100940 | Leung et al. | Jan 2012 | B2 |
| 8118834 | Goraltchouk et al. | Feb 2012 | B1 |
| 8161618 | Maiorino et al. | Apr 2012 | B2 |
| 8192462 | Sulamanidze et al. | Jun 2012 | B2 |
| 8273105 | Cohen et al. | Sep 2012 | B2 |
| 8551137 | Cohen et al. | Oct 2013 | B2 |
| 8888810 | Hadba et al. | Nov 2014 | B2 |
| 9011133 | Marczyk et al. | Apr 2015 | B2 |
| 20010021861 | Boebel et al. | Sep 2001 | A1 |
| 20030032961 | Pelo et al. | Feb 2003 | A1 |
| 20030041426 | Genova et al. | Mar 2003 | A1 |
| 20030149447 | Morency et al. | Aug 2003 | A1 |
| 20040010275 | Jacobs et al. | Jan 2004 | A1 |
| 20040078046 | Barzell et al. | Apr 2004 | A1 |
| 20040093028 | Ruff | May 2004 | A1 |
| 20040226427 | Trull et al. | Nov 2004 | A1 |
| 20040237736 | Genova et al. | Dec 2004 | A1 |
| 20050065542 | Mansfield | Mar 2005 | A1 |
| 20050267531 | Ruff et al. | Dec 2005 | A1 |
| 20060095134 | Trieu et al. | May 2006 | A1 |
| 20060241663 | Rice et al. | Oct 2006 | A1 |
| 20070005109 | Popadiuk et al. | Jan 2007 | A1 |
| 20070005110 | Collier et al. | Jan 2007 | A1 |
| 20070038249 | Kolster | Feb 2007 | A1 |
| 20070065663 | Trull et al. | Mar 2007 | A1 |
| 20070187861 | Genova et al. | Aug 2007 | A1 |
| 20070224237 | Hwang et al. | Sep 2007 | A1 |
| 20070225761 | Shetty | Sep 2007 | A1 |
| 20070257395 | Lindh et al. | Nov 2007 | A1 |
| 20080082113 | Bishop et al. | Apr 2008 | A1 |
| 20080109021 | Medoff | May 2008 | A1 |
| 20080195147 | Stopek | Aug 2008 | A1 |
| 20080221618 | Chen et al. | Sep 2008 | A1 |
| 20080281357 | Sung et al. | Nov 2008 | A1 |
| 20080312688 | Nawrocki et al. | Dec 2008 | A1 |
| 20090076543 | Maiorino et al. | Mar 2009 | A1 |
| 20090112259 | D'Agostino | Apr 2009 | A1 |
| 20090140012 | Greer, Jr. et al. | Jun 2009 | A1 |
| 20090143819 | D'Agostino | Jun 2009 | A1 |
| 20090248066 | Wilkie | Oct 2009 | A1 |
| 20090248070 | Kosa et al. | Oct 2009 | A1 |
| 20090287245 | Ostrovsky et al. | Nov 2009 | A1 |
| 20100016810 | Drews et al. | Jan 2010 | A1 |
| 20100023055 | Rousseau | Jan 2010 | A1 |
| 20100057123 | D'Agostino et al. | Mar 2010 | A1 |
| 20100084780 | Lindh, Sr. et al. | Apr 2010 | A1 |
| 20100146770 | Morency et al. | Jun 2010 | A1 |
| 20100174299 | Viola et al. | Jul 2010 | A1 |
| 20100230300 | Hunter et al. | Sep 2010 | A1 |
| 20100275750 | Maiorino et al. | Nov 2010 | A1 |
| 20100298871 | Ruff et al. | Nov 2010 | A1 |
| 20100313729 | Genova et al. | Dec 2010 | A1 |
| 20110022086 | D'Agostino et al. | Jan 2011 | A1 |
| 20110046668 | Goraltchouk et al. | Feb 2011 | A1 |
| 20110046669 | Goraltchouk et al. | Feb 2011 | A1 |
| 20110125188 | Goraltchouk et al. | May 2011 | A1 |
| 20110190815 | Saliman | Aug 2011 | A1 |
| 20110276090 | Berndt et al. | Nov 2011 | A1 |
| 20110282384 | Odermatt et al. | Nov 2011 | A1 |
| 20110282386 | Friedrich et al. | Nov 2011 | A1 |
| 20110288583 | Goraltchouk et al. | Nov 2011 | A1 |
| 20110288584 | Bojarski et al. | Nov 2011 | A1 |
| 20110319932 | Avelar et al. | Dec 2011 | A1 |
| 20120046675 | Bishop et al. | Feb 2012 | A1 |
| 20120104644 | Lauria | May 2012 | A1 |
| 20120118123 | Maiorino et al. | May 2012 | A1 |
| 20120132054 | Maiorino et al. | May 2012 | A1 |
| 20120197294 | Martin | Aug 2012 | A1 |
| Number | Date | Country |
|---|---|---|
| 1075843 | Feb 2001 | EP |
| 2156795 | Feb 2010 | EP |
| 2 529 670 | Dec 2012 | EP |
| 03007839 | Jan 2003 | WO |
| 2004062459 | Jul 2004 | WO |
| 2007131019 | Nov 2007 | WO |
| 2008042992 | Apr 2008 | WO |
| 2008112417 | Sep 2008 | WO |
| 2008141034 | Nov 2008 | WO |
| 2008157142 | Dec 2008 | WO |
| 2009105663 | Aug 2009 | WO |
| 2009132284 | Oct 2009 | WO |
| 2009129251 | Oct 2009 | WO |
| 2009140012 | Nov 2009 | WO |
| WO 2013026682 | Feb 2013 | WO |
| WO 2014078757 | May 2014 | WO |
| Entry |
|---|
| European Search Report for EP 15305604.9 date of completion is Jul. 1, 2015 (5 pages). |
| Number | Date | Country | |
|---|---|---|---|
| 20160310138 A1 | Oct 2016 | US |
